These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25003653)

  • 1. Chimera-induced folding: implications for amyloidosis.
    Takor GA; Higashiya S; Sorci M; Topilina NI; Belfort G; Welch JT
    Biomacromolecules; 2014 Aug; 15(8):2992-3001. PubMed ID: 25003653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge distribution and amyloid fibril formation: insights from genetically engineered model systems.
    Topilina NI; Sikirzhytsky V; Higashiya S; Ermolenkov VV; Lednev IK; Welch JT
    Biomacromolecules; 2010 Jul; 11(7):1721-6. PubMed ID: 20553038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A de novo designed 11 kDa polypeptide: model for amyloidogenic intrinsically disordered proteins.
    Topilina NI; Ermolenkov VV; Sikirzhytski V; Higashiya S; Lednev IK; Welch JT
    Biopolymers; 2010 Jul; 93(7):607-18. PubMed ID: 20162724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different morphology of amyloid fibrils originating from agitated and non-agitated conditions.
    Buttstedt A; Wostradowski T; Ihling C; Hause G; Sinz A; Schwarz E
    Amyloid; 2013 Jun; 20(2):86-92. PubMed ID: 23570235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
    Booth DR; Sunde M; Bellotti V; Robinson CV; Hutchinson WL; Fraser PE; Hawkins PN; Dobson CM; Radford SE; Blake CC; Pepys MB
    Nature; 1997 Feb; 385(6619):787-93. PubMed ID: 9039909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G; Verine J; Delpech M; Ries M
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme: a paradigmatic molecule for the investigation of protein structure, function and misfolding.
    Merlini G; Bellotti V
    Clin Chim Acta; 2005 Jul; 357(2):168-72. PubMed ID: 15913589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
    Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM
    J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates.
    Cerdà-Costa N; Esteras-Chopo A; Avilés FX; Serrano L; Villegas V
    J Mol Biol; 2007 Mar; 366(4):1351-63. PubMed ID: 17204287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-specific effects of protein topology on cross-beta assembly: studies of insulin fibrillation.
    Huang K; Maiti NC; Phillips NB; Carey PR; Weiss MA
    Biochemistry; 2006 Aug; 45(34):10278-93. PubMed ID: 16922503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D; Silva JL
    Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of water in protein folding, oligomerization, amyloidosis and miniprotein.
    Vajda T; Perczel A
    J Pept Sci; 2014 Oct; 20(10):747-59. PubMed ID: 25098401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seeding-dependent propagation and maturation of amyloid fibril conformation.
    Yamaguchi K; Takahashi S; Kawai T; Naiki H; Goto Y
    J Mol Biol; 2005 Sep; 352(4):952-60. PubMed ID: 16126222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selected aspects of amyloidogenesis].
    Stepkowski D
    Postepy Biochem; 2012; 58(1):110-4. PubMed ID: 23214135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.